Cecile Viboud
Overview
Explore the profile of Cecile Viboud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
339
Citations
17754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nunes M, Chauvel C, Raboni S, Lopez-Labrador F, Andrew M, Badar N, et al.
Influenza Other Respir Viruses
. 2025 Mar;
19(3):e70091.
PMID: 40082217
Respiratory viruses represent a significant public health threat. There is the need for robust and coordinated surveillance to guide global health responses. Established in 2012, the Global Influenza Hospital Surveillance...
2.
Tran-Kiem C, Paredes M, Perofsky A, Frisbie L, Xie H, Kong K, et al.
Nature
. 2025 Mar;
PMID: 40044856
Pathogen genomics can provide insights into underlying infectious disease transmission patterns, but new methods are needed to handle modern large-scale pathogen genome datasets and realize this full potential. In particular,...
3.
Viboud C, Neuzil K
Lancet Glob Health
. 2025 Jan;
13(2):e173-e174.
PMID: 39890212
No abstract available.
4.
Chen Z, Tsui J, Cai J, Su S, Viboud C, du Plessis L, et al.
Nat Commun
. 2025 Jan;
16(1):475.
PMID: 39774646
East, South, and Southeast Asia (together referred to as Southeastern Asia hereafter) have been recognized as critical areas fuelling the global circulation of seasonal influenza. However, the seasonal influenza migration...
5.
Tsang T, Du Q, Cowling B, Viboud C
Nat Commun
. 2024 Oct;
15(1):8625.
PMID: 39366942
Forecasting influenza activity in tropical and subtropical regions, such as Hong Kong, is challenging due to irregular seasonality and high variability. We develop a diverse set of statistical, machine learning,...
6.
Perofsky A, Huddleston J, Hansen C, Barnes J, Rowe T, Xu X, et al.
Elife
. 2024 Sep;
13.
PMID: 39319780
Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals,...
7.
Loo S, Chinazzi M, Srivastava A, Venkatramanan S, Truelove S, Viboud C
Epidemics
. 2024 Aug;
48:100788.
PMID: 39209676
No abstract available.
8.
Hansen C, Viboud C, Simonsen L
Elife
. 2024 Aug;
13.
PMID: 39190600
Cancer is considered a risk factor for COVID-19 mortality, yet several countries have reported that deaths with a primary code of cancer remained within historic levels during the COVID-19 pandemic....
9.
Sun K, Bhiman J, Tempia S, Kleynhans J, Madzorera V, Mkhize Q, et al.
Nat Med
. 2024 Jul;
30(10):2805-2812.
PMID: 39060660
Serum neutralizing antibodies (nAbs) induced by vaccination have been linked to protection against symptomatic and severe coronavirus disease 2019. However, much less is known about the efficacy of nAbs in...
10.
Mathis S, Webber A, Leon T, Murray E, Sun M, White L, et al.
Nat Commun
. 2024 Jul;
15(1):6289.
PMID: 39060259
Accurate forecasts can enable more effective public health responses during seasonal influenza epidemics. For the 2021-22 and 2022-23 influenza seasons, 26 forecasting teams provided national and jurisdiction-specific probabilistic predictions of...